Human NLRC4 and CASP4 inflammasomes activate GSDMD-mediated killing of S. flexneri independently of macrophage pyroptosis and bacterial cardiolipin 2254736

Abstract Introduction Elimination of the infecting pathogen is a core function of the immune system. Macrophages are a crucial component of innate immunity against bacterial infections as they internalize and kill intracellular bacteria. Although macrophage restriction of some intracellular bacteria depends on inflammasomes, the specific mechanisms of inflammasome-mediated killing of bacteria are incompletely understood. Methods The role of inflammasomes in macrophage killing of Shigella flexneri is assessed by quantification of intracellular bacteria during infection of wild-type human-derived THP-1 macrophages and macrophages deficient in inflammasome components. Chloroquine resistance assay is used to assess IFNγ impact on vacuolar escape. Pyroptosis and GSDMD pore formation are inhibited with glycine and disulfiram. To assess GSDMD-mediated killing, GSDMD-/- macrophages are used and GSDMD is expressed ectopically in HEK293T cells. Results I found that S. flexneri is restricted in human macrophages and that macrophage restriction is enhanced by priming with IFNγ. IFNγ does not impact bacterial internalization and vacuolar escape, indicating that the intracellular restriction takes place in the cytosol. IFNγ priming results in killing of S. flexneri independently of pyroptosis and macrophage lysis. I found that macrophage restriction depends on NLRC4-mediated activation of CASP1 and GSDMD in unprimed macrophages. In contrast, I found that CASP4 is required for efficient IFNγ-dependent killing of S. flexneri and that IFNγ upregulates CASP4 and enhances bacterial restriction independently of GBP1 and NLRP11. Expression of GSDMD in HEK293T cells leads to killing of intracellular S. flexneri. GSDMD kills S. flexneri lacking cardiolipin and when oxidative stress is inhibited. Conclusion GSDMD is the executioner of inflammasome-mediated killing of S. flexneri. A new mechanism of GSDMD antibacterial activity is identified as GSDMD kills S. flexneri independently of cardiolipin and oxidative stress. Funding Source NIH T32 AI007061, NIH F32 AI188955 Topic Categories Innate Immune Responses and Host Defense: Molecular Mechanisms (INM)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.240
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human NLRC4 and CASP4 inflammasomes activate GSDMD-mediated killing of S. flexneri independently of macrophage pyroptosis and bacterial cardiolipin 2254736

María Luisa Gil-Marqués, Mateusz Szczerba, Marcia Goldberg
The Journal of Immunology
Inflammasome and immune disorders
article

Human NLRC4 and CASP4 inflammasomes activate GSDMD-mediated killing of S. flexneri independently of macrophage pyroptosis and bacterial cardiolipin 2254736

María Luisa Gil-Marqués, Mateusz Szczerba, Marcia Goldberg
article en

Abstract

Abstract Introduction Elimination of the infecting pathogen is a core function of the immune system. Macrophages are a crucial component of innate immunity against bacterial infections as they internalize and kill intracellular bacteria. Although macrophage restriction of some intracellular bacteria depends on inflammasomes, the specific mechanisms of inflammasome-mediated killing of bacteria are incompletely understood. Methods The role of inflammasomes in macrophage killing of Shigella flexneri is assessed by quantification of intracellular bacteria during infection of wild-type human-derived THP-1 macrophages and macrophages deficient in inflammasome components. Chloroquine resistance assay is used to assess IFNγ impact on vacuolar escape. Pyroptosis and GSDMD pore formation are inhibited with glycine and disulfiram. To assess GSDMD-mediated killing, GSDMD-/- macrophages are used and GSDMD is expressed ectopically in HEK293T cells. Results I found that S. flexneri is restricted in human macrophages and that macrophage restriction is enhanced by priming with IFNγ. IFNγ does not impact bacterial internalization and vacuolar escape, indicating that the intracellular restriction takes place in the cytosol. IFNγ priming results in killing of S. flexneri independently of pyroptosis and macrophage lysis. I found that macrophage restriction depends on NLRC4-mediated activation of CASP1 and GSDMD in unprimed macrophages. In contrast, I found that CASP4 is required for efficient IFNγ-dependent killing of S. flexneri and that IFNγ upregulates CASP4 and enhances bacterial restriction independently of GBP1 and NLRP11. Expression of GSDMD in HEK293T cells leads to killing of intracellular S. flexneri. GSDMD kills S. flexneri lacking cardiolipin and when oxidative stress is inhibited. Conclusion GSDMD is the executioner of inflammasome-mediated killing of S. flexneri. A new mechanism of GSDMD antibacterial activity is identified as GSDMD kills S. flexneri independently of cardiolipin and oxidative stress. Funding Source NIH T32 AI007061, NIH F32 AI188955 Topic Categories Innate Immune Responses and Host Defense: Molecular Mechanisms (INM)

The Journal of ImmunologyVol. 215(Supplement_1)
Broad Institute (US), Harvard University (US), Massachusetts General Hospital (US)
Openalex Percentile: Top 14%
Inflammasome and immune disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.